Results 51 to 60 of about 2,920 (197)
Cardiovascular risk factors in patients with calcium pyrophosphate crystal deposition disease
Calcium pyrophosphate crystal deposition disease (CPCDD) is among the most common inflammatory rheumatic diseases; however, studies of cardiovascular risks in CPCDD have not been conducted.Objective: to stratify a cardiovascular risk in patients with ...
M. S. Eliseev +3 more
doaj +1 more source
This study reveals a unique active site enriched in methionine residues and demonstrates that these residues play a critical role by stabilizing carbocation intermediates through novel sulfur–cation interactions. Structure‐guided mutagenesis further revealed variants with significantly altered product profiles, enhancing pseudopterosin formation. These
Marion Ringel +13 more
wiley +1 more source
USE OF METHOTREXATE IN PATIENTS WITH CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
Objective: to compare the efficacy of methotrexate (MTX) and colchicine in patients with chronic arthritis in calcium pyrophosphate crystal deposition disease (CPPDD).Subjects and methods.
M. S. Eliseev +2 more
doaj +1 more source
Advanced imaging techniques in crystal arthritis
Gout and calcium pyrophosphate deposition (CPPD) disease are the most common causes of crystal arthritis. Identifying the pathogenic crystal deposition is the cornerstone of the diagnosis, but also prognosis and monitoring of the diseases.
Victor Laurent +3 more
doaj +1 more source
This study explored the role of the class IIa histone deacetylase HDAC7 in hepatic inflammation and metabolic disease. Genetic approaches in mice revealed that myeloid HDAC7 drives hepatic inflammation and gene signatures associated with advanced chronic liver disease.
Yizhuo Wang +27 more
wiley +1 more source
CPPD—differential diagnostics and differential therapeutic challenges [PDF]
Calcium pyrophosphate deposition disease (CPPD), characterized by the presence of calcium pyrophosphate crystals in and around joints, poses diagnostic and therapeutic challenges in rheumatology.
Maria L. Voulgari, Herbert Kellner
doaj +1 more source
Vascular Calcification: Mechanisms, Models, and Therapies
ABSTRACT Vascular calcification represents an active multifactorial process that mirrors several key features of skeletal bone mineralization. Clinically, it is characterized by diminished arterial compliance and increased arterial wall stiffness, both of which serve as independent predictors of significant adverse cardiovascular events.
Wenya Zhu +5 more
wiley +1 more source
Seropositive Rheumatoid Arthritis Emerging During Acute Phase of Lung Abscess: A Case Report
We report a rare case of seropositive rheumatoid arthritis (RA) that became clinically apparent during the acute phase of lung infection. This case demonstrates that RA can be diagnosed during the acute course of a respiratory infection and highlights the diagnostic value of rheumatoid factor and anti‐citrullinated protein antibodies testing when new ...
Yusuke Arai +5 more
wiley +1 more source
Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son +13 more
wiley +1 more source
Calcium Pyrophosphate and Basic Calcium Phosphate Deposition Diseases: The Year in Review 2022
Calcium-containing crystal deposition diseases are a common cause of pain and disability but remain relatively under-investigated. No drug has been identified that can prevent deposition or effect dissolution of either calcium pyrophosphate (CPP) or ...
Geraldine Mary McCarthy
core +1 more source

